Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.
about
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.Treatment for recurrent ovarian cancer-at first relapse.Pegylated liposomal doxorubicin in the management of ovarian cancerMetronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter studyOptimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?Pegylated liposomal doxorubicin in ovarian cancer.Clinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancerPegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancerPharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.Use of pegylated liposomal doxorubicin in the management of platinum-sensitive recurrent ovarian cancer: current concepts.Pegylated liposomal doxorubicin in ovarian cancer.Role of gemcitabine in the treatment of ovarian cancer.
P2860
Q33397131-91B887D3-C27A-4118-8C87-F485E15B0CEAQ33570711-5E208D0F-938A-4497-B19A-ED2B5FF634C9Q34187661-105ABEC7-8C76-434E-BDD2-68DDCF0BDEBAQ34993605-56AF1047-A26F-4FB0-9F61-34FD6E87BBBEQ36488198-B201FA7D-9BCF-4731-8DD6-1D2459CE3117Q36718020-2166AEB1-6BE7-48F7-9EE6-3FF108679867Q36728989-8821C197-EA3F-448C-B76C-94981230002CQ36740641-EF3B767C-D6D2-421E-A412-790154991DCDQ37276254-913056E6-920E-419B-87D1-5D0224963ACCQ37857281-89D4D9B2-51C5-4D35-9DC4-CAE40C53830FQ37965631-130A9FE6-1709-46A5-8C64-56897F392A12Q43065300-77AF2D5F-B67C-4E89-85A6-FC7AA87DD15CQ43267035-B222B846-5C74-4135-A5A7-7B71AA81C262
P2860
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@en
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@nl
type
label
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@en
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@nl
prefLabel
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@en
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@nl
P2093
P1433
P1476
Gemcitabine and liposomal doxo ...... esults and long-term survival.
@en
P2093
Antonia Testa
Enrico Breda
Gabriella Ferrandina
Giovanni Scambia
Giuseppa Pezzella
Giuseppe D'Agostino
Manuela Ludovisi
Mariangela Zanghi
Salvatore Pisconti
P304
P356
10.1016/J.YGYNO.2005.04.018
P407
P577
2005-08-01T00:00:00Z